Purchase Order W81K0015P0697

Award Date 9/29/15
Potential Completion Date 9/29/15
Potential Value $128K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $147,681.00 Firm Fixed Price Purchase Order awarded by the Department of the Army Medical Command to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is to provide Cultured EPICEL-CEA surgical implants and membranes in support of the Department of Veterans Affairs' (VA) healthcare programs for veterans. Vericel Corporation is a small business that has been awarded over 50 similar federal contracts from 2015-2023 to supply specialized...
The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order contract to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, to provide Epicel (Cultured Epidermal Autografts) grafts for a patient-specific surgery. The $169,149.00 contract was awarded on May 22, 2018, with a completion date of June 14, 2018. The contract did not have a set-aside designation. Vericel Corporation is an experienced federal contractor, having been awarded over...
The Department of the Army Medical Command awarded a Firm Fixed Price Purchase Order contract to Vericel Corporation, a for-profit manufacturer of medical goods, to provide Cultured EPICEL-CEA skin grafts. The contract has a potential value of $228,275.00 and a completion date of January 3, 2019. The contract was awarded on December 31, 2018 without a set-aside designation. Vericel Corporation is a leader in advanced cell therapies for the sports medicine and severe burn care markets, and has...
This federal contract award, with an ID of 36C25225P0240, was issued by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The $56,171.00 firm fixed-price purchase order is for the delivery of IMPLANT products, which are likely advanced cell therapy and surgical implants used in orthopedic and reconstructive procedures. The contract has no set-aside designation, indicating it was competed on the open...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products for sports medicine and severe burn care. The $56,171 contract is for the delivery of surgical implants, membranes, and other biological products to support healthcare services for veterans at VA facilities. The contract has a completion date of May 29, 2024 and was awarded on March...
This federal contract award, valued at $56,171.00, was issued by the Veterans Integrated Service Network 12 (VISN 12), which is part of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, primarily for the supply of the company's MACI cultured chondrocyte implant and other surgical implants, membranes, and biological products. The contract is a firm fixed price purchase order with a completion...
This federal contract award is for the supply of a surgical implant (tissue) by Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, to the Department of Veterans Affairs (VA). The $52,252.00 firm fixed price purchase order is not set aside and has a completion date of June 26, 2023. Vericel, which has been a registered federal contractor since 2015, has secured over 50 contracts with the VA's Veterans Health Administration, primarily to provide specialized medical...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The $52,252 contract is for the delivery of surgical implants, with a period of performance ending on November 22, 2023. Vericel Corporation is a registered federal contractor that has secured over 50 contracts with the VA and the Defense Health Agency since 2015, primarily to provide specialized medical...
This federal contract award, valued at $56,171.00, was made by the U.S. Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is for the provision of IMPLANT, a surgical implant product, with an ultimate completion date of August 16, 2024. This contract was not set aside for a specific business type. Vericel Corporation, a long-standing federal contractor since 2015, has secured numerous contracts with the VA and the...
This federal contract award was issued by the Defense Health Agency to Vericel Corporation, a medical technology company based in Cambridge, Massachusetts. The $47,204.00 firm fixed-price purchase order is for the delivery of MACI (matrix-induced autologous chondrocyte implantation) cultured chondrocyte implants, surgical implants, membranes, and biological products used in cartilage repair procedures. The award does not have a set-aside designation, indicating Vericel competed on the open...

This is a $127,809 firm fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The contract is for the supply of EPICEL-CEA skin grafts, which are advanced cell therapy products used in orthopedic and reconstructive medical procedures. Vericel specializes in developing innovative cell and tissue-based therapies, and this contract supports the company's role in providing critical medical technologies to the Department of Veterans Affairs (VA) and the Defense Health Agency. The contract has no set-aside designation, indicating Vericel competed for this award on the open market. This award is part of Vericel's ongoing federal contract work with various VA regional networks, demonstrating the company's importance in delivering specialized medical implants and biological products to support healthcare services for veterans and military personnel.

Generated 4/1/25, 5:26 PM